This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
Have you ever wondered what China and Russia would talk about if they were to discuss AI in healthcare? It turns out they do just that—and a newly published academic paper straight out of the Russian Federation offers a glimpse into the dialogue.
Staying vaccinated as recommended by doctors can help patients limit their risk of adverse cardiovascular events, according to a new consensus statement published in European Heart Journal.
Research into the design and development of AI models for rural healthcare isn’t hard to come by. However, that’s about as far as most of the investigations go.
“We can reach tissues, bones and organs with high spatial precision that haven’t been reachable with light-based printing methods," one researcher explained.
The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent.
In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.